Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Perimeter Medical Imaging AI ( (TSE:PINK) ) has issued an update.
Perimeter Medical Imaging AI reported significant financial growth in 2024, with a 303% increase in Q4 revenues compared to the previous year, driven by the adoption of its S-Series OCT systems. The company is advancing its B-Series OCT system, having successfully completed a pivotal trial for breast-conserving surgeries and submitted a PMA application to the FDA. This progress positions Perimeter for further expansion and potential regulatory approval, which could enhance its market position and impact stakeholders positively.
More about Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc. is a commercial-stage medical technology company operating in the healthcare industry. The company focuses on developing advanced imaging technologies, particularly optical coherence tomography (OCT) systems, to aid in surgical procedures. Their primary products include the FDA-cleared Perimeter S-Series OCT and the next-generation Perimeter B-Series OCT, which integrates AI technology for enhanced imaging capabilities. The company is actively expanding its market presence in the United States.
YTD Price Performance: 33.33%
Average Trading Volume: 82,112
Technical Sentiment Signal: Buy
Current Market Cap: C$53.1M
See more data about PINK stock on TipRanks’ Stock Analysis page.